Viewing nowCombinationEmpagliflozin/Metformin Hydrochloride Tablets 12.5/1000 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Aprogen Pharmaceuticals Co., Ltd.

MFDS item code 202302659 · Approved 2023.09.06 · Insurance code 645211010
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication improves blood sugar control in adults with type 2 diabetes when used alongside diet and exercise therapy, combining empagliflozin and metformin. It is especially effective when blood sugar is inadequately controlled, and caution is recommended for use in type 2 diabetes patients with cardiovascular disease. This medication aids in stable blood sugar management and benefits diabetes treatment.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients taking this medicine whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients in Whom This Medicine Is Contraindicated, item 2). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication is used for treating diabetes and helps regulate blood sugar levels. However, there are several important precautions to take: First, this medication can cause a rare side effect called severe lactic acidosis, which can be life-threatening and requires special attention. Second, when taken with insulin or other diabetes medications, hypoglycemia may occur, so blood sugar changes should be closely monitored. Third, patients with poor kidney function or conditions such as severe infection, dehydration, or acute myocardial infarction should not take this medication. Fourth, it is safer for women who are pregnant or breastfeeding to avoid using this medication. Fifth, during treatment, regular checks of kidney function, blood sugar, and lactate levels should be conducted to ensure there are no abnormal signs. Sixth, if examinations involve iodine contrast agents, this medication should be temporarily stopped, and resumed only after kidney function is confirmed to be normal. Seventh, this medication can cause dehydration or low blood pressure, so elderly patients or those with cardiovascular disease should carefully manage their fluid status. Eighth, genital or urinary tract infections may occur, so immediate consultation with a doctor is necessary if symptoms appear. Ninth, this medication can lower vitamin B12 levels, so monitoring vitamin B12 levels during long-term use is necessary. Finally, excessive alcohol consumption should be avoided while taking this medication, and any signs of hypoglycemia or lactic acidosis should be reported immediately to healthcare professionals.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
Biconvex, oval, film-coated tablet with a dark brownish-purple color.
60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Aprogen Pharmaceuticals Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.